Duke iPSC Cells Restore Retinal Function in Mice, Regenerating Blood Vessels Against Vision Loss
Updated
Updated · Good News Network · Jul 6
Duke iPSC Cells Restore Retinal Function in Mice, Regenerating Blood Vessels Against Vision Loss
3 articles · Updated · Good News Network · Jul 6
Summary
Duke researchers injected lab-grown retinal endothelial cells into mice with retinal disease and restored retinal function while rebuilding damaged blood vessels, including in a model of diabetic retinopathy.
The team made the cells from induced pluripotent stem cells, then used growth factors to turn them into retina-specific vessel cells that also formed functional vascular tissue in lab experiments.
Low-oxygen and high-glucose tests caused the lab-grown retinal barrier to break down like it does in diabetes, giving researchers a human tissue model for studying disease and testing therapies.
The approach could cut costs and expand supply versus harvesting retinal endothelial cells from patients, and Duke is now pursuing industry partnerships with a patent pending on the therapy and drug-discovery platform.
After restoring vision in mice, what is the biggest hurdle preventing human trials for this groundbreaking stem cell therapy?
This therapy fixes retinal blood vessels, but can it reverse blindness if the eye's neurons are already permanently damaged?
Lab-Grown Retinal Endothelial Cells Restore Vision: Duke University’s 2026 Stem Cell Breakthrough and Its Impact on Retinal Disease Treatment
Overview
Duke University researchers have made a major breakthrough by creating specialized retinal endothelial cells from induced pluripotent stem cells (iPSCs), as detailed in a recent publication. These cells are crucial because they do not naturally form elsewhere in the body, and their breakdown is a leading cause of vision loss. Traditionally, sourcing these cells from patients is expensive and limited. The Duke team’s innovation allows for a continuous, renewable supply of these cells, making it easier to study and develop treatments for retinal diseases and offering new hope for restoring vision.